Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Schlaberg

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Sexually Transmitted Infections|May 16, 2014
Chlamydia trachomatis L serovars and dominance of novel L2b ompA variants, U.S.ABrian A Kendall, Keith D Tardif, Robert Schlaberg
Archives of Pathology & Laboratory Medicine|January 3, 2012
Verification of performance specifications for a US Food and Drug Administration-approved molecular microbiology test: Clostridium difficile cytotoxin B using the Becton, Dickinson and Company GeneOhm Cdiff assayRobert Schlaberg, Michael J Mitchell, Edward W Taggart, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 11, 2014
Simultaneous titration and phenotypic antiviral drug susceptibility testing for herpes simplex virus 1 and 2Keith D Tardif, Shane Jorgensen, Janine Langer, et al.
Journal of Clinical Microbiology|February 21, 2014
Testing and genotyping of high-risk human papillomavirus by the cobas HPV Test and the Hybrid Capture 2 high-risk HPV DNA test using cervical and vaginal samplesMichael T Pyne, Christian Law, David R Hillyard, et al.
Journal of Virological Methods|May 10, 2015
High-risk HPV detection and genotyping by APTIMA HPV using cervical samplesMichael T Pyne, Camille L Hamula, Keith Tardif, et al.
The New England Journal of Medicine|September 30, 2016
Fatal Zika Virus Infection with Secondary Nonsexual TransmissionSankar Swaminathan, Robert Schlaberg, Julia Lewis, et al.
Antimicrobial Agents and Chemotherapy|June 19, 2002
Neuroprotection and reduced proliferation of microglia in ribavirin-treated bornavirus-infected ratsMarylou V Solbrig, Robert Schlaberg, Thomas Briese, et al.
Archives of Pathology & Laboratory Medicine|February 8, 2017
Validation of Metagenomic Next-Generation Sequencing Tests for Universal Pathogen DetectionRobert Schlaberg, Charles Y Chiu, Steve Miller, et al.
Plos One|February 25, 2016
Cervical Cytology Specimen Stability in Surepath Preservative and Analytical Sensitivity for HPV Testing with the cobas and Hybrid Capture 2 TestsKeith D Tardif, Michael T Pyne, Elisabeth Malmberg, et al.
Journal of Clinical Laboratory Analysis|May 21, 2013
tcdA As a diagnostic target in a loop-mediated amplification assay for detecting toxigenic Clostridium difficileBrianne Couturier, Robert Schlaberg, Chris Konzak, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Sexually Transmitted Infections|May 16, 2014
Chlamydia trachomatis L serovars and dominance of novel L2b ompA variants, U.S.ABrian A Kendall, Keith D Tardif, Robert Schlaberg
Archives of Pathology & Laboratory Medicine|January 3, 2012
Verification of performance specifications for a US Food and Drug Administration-approved molecular microbiology test: Clostridium difficile cytotoxin B using the Becton, Dickinson and Company GeneOhm Cdiff assayRobert Schlaberg, Michael J Mitchell, Edward W Taggart, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 11, 2014
Simultaneous titration and phenotypic antiviral drug susceptibility testing for herpes simplex virus 1 and 2Keith D Tardif, Shane Jorgensen, Janine Langer, et al.
Journal of Clinical Microbiology|February 21, 2014
Testing and genotyping of high-risk human papillomavirus by the cobas HPV Test and the Hybrid Capture 2 high-risk HPV DNA test using cervical and vaginal samplesMichael T Pyne, Christian Law, David R Hillyard, et al.
Journal of Virological Methods|May 10, 2015
High-risk HPV detection and genotyping by APTIMA HPV using cervical samplesMichael T Pyne, Camille L Hamula, Keith Tardif, et al.
The New England Journal of Medicine|September 30, 2016
Fatal Zika Virus Infection with Secondary Nonsexual TransmissionSankar Swaminathan, Robert Schlaberg, Julia Lewis, et al.
Antimicrobial Agents and Chemotherapy|June 19, 2002
Neuroprotection and reduced proliferation of microglia in ribavirin-treated bornavirus-infected ratsMarylou V Solbrig, Robert Schlaberg, Thomas Briese, et al.
Archives of Pathology & Laboratory Medicine|February 8, 2017
Validation of Metagenomic Next-Generation Sequencing Tests for Universal Pathogen DetectionRobert Schlaberg, Charles Y Chiu, Steve Miller, et al.
Plos One|February 25, 2016
Cervical Cytology Specimen Stability in Surepath Preservative and Analytical Sensitivity for HPV Testing with the cobas and Hybrid Capture 2 TestsKeith D Tardif, Michael T Pyne, Elisabeth Malmberg, et al.
Journal of Clinical Laboratory Analysis|May 21, 2013
tcdA As a diagnostic target in a loop-mediated amplification assay for detecting toxigenic Clostridium difficileBrianne Couturier, Robert Schlaberg, Chris Konzak, et al.
Pageof 5